Winston & Strawn represented Docter Inc. in the transaction, while Robinson & Cole represented Aimfinity. Docter Inc., a Taiwanese non-invasive blood glucose watch developer, announced the definitive...
This content is for Standard 1 Year members only. LoginJoin Now